You are here

Home

PRESENTATION AT THE NORWEGIAN HEALTHCARE CAPITAL MARKETS DAY IN LONDON

20 January 2011: Enclosed you will find the presentation from today's conference.
 
Contact:
CEO Mårten Wigstøl, Phone: + 47 911 65775
CFO Tone Kvåle, Phone: +47 915 19576
 
About NorDiag:
NorDiag is a biotechnology company developing, manufacturing and marketing automated solutions (instruments and tests) for sample preparation of DNA from difficult biological samples. DNA diagnostics give more rapid and precise answers, and are the fastest growing field within diagnostics. The company's sample preparation solutions are today used in connection with STI, tuberculosis, MRSA, respiratory pathogens and viruses on instruments for large and small laboratories. NorDiag was founded in 2003 and has its headquarters in Oslo, Norway. The company has offices and laboratories in Stockholm, Sweden, in West Chester (PA), USA and in Vienna, Austria. The group has today 40 man-labour years. NorDiag is listed on Oslo Stock Exchange with ticker NORD.
For further information - www.nordiag.com.

Read the presentation here

Read the notice in Norwegian here